The Charles-Bruneau Foundation has announced a historic five-year, $50 million commitment (2025–2030) to support pediatric hematology-oncology research across Quebec’s four university hospital centres — including the Montreal Children’s Hospital.
This unprecedented investment will fund collaborative projects that advance personalized medicine, psychosocial oncology and the training of the next generation of scientists, all aimed at achieving one shared goal: a childhood without cancer and a recovery without after-effects.
“This commitment allows us to go further — to develop targeted therapies for children with few treatment options, to improve outcomes for resistant cancers, and to enhance quality of life for survivors and their families,” said Nada Jabado, OC, MD, PhD, Senior Scientist in Child Health and Human Development Program the Research Institute of the McGill University Health Centre (The Institute) and Pediatric Hemato-Oncologist at the Montreal Children’s Hospital, in the Foundation announcement. “It brings us closer to a world where no child has to face cancer.”